UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13A-16 OR 15D-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934
October 15, 2026
Commission File Number: 000-17444
Akzo Nobel N.V.
Christian Neefestraat 2
1077 WW Amsterdam
The Netherlands
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
| Form 20-F ☒ | Form 40-F ☐ |
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐
The following exhibit is furnished herewith:
Exhibit Index
| Exhibit Number | Description of Exhibit |
| 99.1 | AkzoNobel and Axalta to be called Axanzo following merger |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
Akzo Nobel N.V.
Date: October 15, 2026
By:
/s/ Grégoire Poux-Guillaume
Name:
Grégoire Poux-Guillaume
Title:
Chief Executive Officer
Date: October 15, 2026
By:
/s/ Maarten de Vries
Name:
Maarten de Vries
Title:
Chief Financial Officer